Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Oncodesign applies its Nanocyclix technology to Sanofi's kinase projects

Executive Summary

Oncodesign SA (drug discovery tools for oncology therapeutics) will apply its Nanocyclix medicinal chemistry technology to several of Sanofi’s kinase target programs in development. Specific projects and therapeutic areas were not disclosed.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Technologies
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • R&D and Marketing (Licensing)

Related Companies